Assignee
SUNOVION PHARMACEUTICALS INC
US·91 granted patents·58 pending applications·252 citations·filing 2006–2023
Top patents by PatentIndex Score
149 records- 0197US10874639B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Dec 29, 2020·8 cites·30 claims
- 0297US10660875B1Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted May 26, 2020·10 cites·24 claims
- 0397US10377708B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Aug 13, 2019·13 cites·22 claims
- 0496US11370753B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·5 cites·12 claims
- 0596US10577317B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Mar 3, 2020·10 cites·42 claims
- 0695US10894033B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Jan 19, 2021·3 cites·21 claims
- 0795US10369134B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Aug 6, 2019·14 cites·29 claims
- 0895US10285953B2Sublingual filmsSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted May 14, 2019·17 cites·22 claims
- 0994US10576058B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Mar 3, 2020·10 cites·6 claims
- 1093US11517558B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Dec 6, 2022·2 cites·20 claims
- 1193US11440921B2Salts, crystal forms, and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Sep 13, 2022·3 cites·21 claims
- 1292US11654113B2Modified release formulations and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2021·Granted May 23, 2023·3 cites·24 claims
- 1392US11160758B2Modified release formulations and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Nov 2, 2021·6 cites·29 claims
- 1492US10815249B2Salts, crystal forms, and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·6 cites·44 claims
- 1592US10800738B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Oct 13, 2020·3 cites·70 claims
- 1691US10196403B2Compounds and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 5, 2019·8 cites·44 claims
- 1791US10085968B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Oct 2, 2018·7 cites·60 claims
- 1891US9669019B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·6 cites·31 claims
- 1991US9669021B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·6 cites·22 claims
- 2091US9351954B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·10 cites·37 claims
- 2191US8053603B2Tetralone-based monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2006·Granted Nov 8, 2011·24 cites·23 claims
- 2290US11767293B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Granted Sep 26, 2023·1 cites·12 claims
- 2389US11129807B2Methods of treating schizophreniaSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Sep 28, 2021·5 cites·22 claims
- 2489US10336732B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·7 cites·20 claims
- 2589US9669018B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·5 cites·29 claims
- 2689US9669020B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·5 cites·26 claims
- 2788US10420763B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Sep 24, 2019·3 cites·13 claims
- 2887US11491133B2Heteroaryl-isochroman compounds and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Nov 8, 2022·2 cites·57 claims
- 2987US9249162B2Substituted [1,2,4]triazolo[1,5-a]pyridines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·7 cites·27 claims
- 3086US10562916B2Substituted quinoxalines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·4 cites·24 claims
- 3186US10449146B2Methods of treating parkinson's disease by administration of apomorphine to an oral mucosaSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·2 cites·13 claims
- 3286US9072699B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Jul 7, 2015·4 cites·6 claims
- 3384US12161623B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Granted Dec 10, 2024·0 cites·15 claims
- 3483US10959943B2Methods of treating Parkinson's disease by administration of apomorphine to an oral mucosaSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Mar 30, 2021·1 cites·52 claims
- 3583US8344030B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2012·Granted Jan 1, 2013·3 cites·6 claims
- 3682US10815042B2Easy-open peel pouchSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Oct 27, 2020·6 cites·15 claims
- 3782US10702486B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Jul 7, 2020·0 cites·6 claims
- 3881US11738002B2Methods of treating neurological and psychiatric disordersSUNOVION PHARMACEUTICALS INC·Filed 2021·Granted Aug 29, 2023·1 cites·21 claims
- 3981US11136304B2Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Oct 5, 2021·1 cites·22 claims
- 4081US10556890B2Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 11, 2020·2 cites·14 claims
- 4181US9758529B2Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Sep 12, 2017·3 cites·54 claims
- 4280US10780074B2Compounds and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Sep 22, 2020·2 cites·55 claims
- 4380US8754117B2Pyrrolidine triple reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Jun 17, 2014·3 cites·26 claims
- 4480US7964753B2Formoterol tartrate process and polymorphSUNOVION PHARMACEUTICALS INC·Filed 2010·Granted Jun 21, 2011·2 cites·3 claims
- 4580US2022387382A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4679US9856238B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·2 cites·33 claims
- 4779US9040588B2Acetamide stereoisomerSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·1 cites·15 claims
- 4878US9133117B2Triple reuptake inhibitors and methods of their useSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Sep 15, 2015·2 cites·21 claims
- 4978US2020030315A1Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 5077US2021046021A1TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINESUNOVION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 149 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SUNOVION PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →